Maravai Lifesciences Holdings (MRVI) Non-Current Deferred Tax Liability (2020 - 2025)

Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability history runs 5 years deep, the most recent figure standing at $2.0 million for Q2 2025.

• On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $2.0 million in Q2 2025; TTM through Jun 2025 was $2.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $11000.0, changed N/A from the prior year.
• Non-Current Deferred Tax Liability grew to $2.0 million in Q2 2025 per MRVI's latest filing, from $2.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $8.7 million in Q1 2023 and bottomed at $11000.0 in Q4 2024.
• The 4-year median for Non-Current Deferred Tax Liability is $6.7 million (2023), against an average of $5.2 million.